Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions

Characteristic Features of Stem Cells in Glioblastomas: From Cellular Biology to Genetics

(2012) Mark J. Knights et al.   BRAIN PATHOLOGY

Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation

(2012) Anthony B. Mak et al.   Cell Reports

Expression and regulation of AC133 and CD133 in glioblastoma

(2011) Benito Campos et al.   GLIA

High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma

(2011) A. Raso et al.   NEURO-ONCOLOGY

A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma

(2010) Ruihuan Chen et al.   CANCER CELL

Insight into the complex regulation of CD133 in glioma

(2010) Benito Campos et al.   INTERNATIONAL JOURNAL OF CANCER

The therapeutic promise of the cancer stem cell concept

(2010) Natasha Y. Frank et al.   JOURNAL OF CLINICAL INVESTIGATION

A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival

(2010) Prasenjit Das et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Expression of macrophage inflammatory protein-1α and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: Involvement of ATP and P2X7 receptor

(2010) Kuan-Min Fang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells

(2010) J. M. Angelastro et al.   MOLECULAR CANCER RESEARCH

Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways

(2009) Hui-Wen Chiu et al.   Autophagy

Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression

(2009) Charn-Jung Chang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas

(2009) Yunbo Zhen et al.   CANCER LETTERS

Targeting CD133 antigen in cancer

(2009) Gabriella Ferrandina et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Limits of CD133 as a marker of glioma self-renewing cells

(2009) Virginie Clément et al.   INTERNATIONAL JOURNAL OF CANCER

Brain cancer stem cells

(2009) Sara G. M. Piccirillo et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells

(2008) W Chearwae et al.   BRITISH JOURNAL OF CANCER

Inhibitory regulation of glutamate aspartate transporter (GLAST) expression in astrocytes by cadmium-induced calcium influx

(2008) Yu-Peng Liu et al.   JOURNAL OF NEUROCHEMISTRY

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

(2008) Kyeung Min Joo et al.   LABORATORY INVESTIGATION

IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS

(2008) Alfred T. Ogden et al.   NEUROSURGERY

CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain

(2008) V. Coskun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

(2007) Jian Wang et al.   INTERNATIONAL JOURNAL OF CANCER